American Capital Advisory, LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 2018007
KETCHUM, ID
Position in NBIX
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$1,011
+$870 QoQ
Shares Held
6
+500.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#747
of 768 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026American Capital Advisory, LLC holds $41,172 across 9 Drug Manufacturers - Specialty & Generic names. NBIX ranks #7 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
386 | $27,737 | |
| 2 | VTRS |
Viatris Inc
|
225 | $3,573 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
177 | $2,837 | |
| 4 | HLN |
Haleon plc
|
219 | $2,043 | |
| 5 | GLAS |
Glass House Brands Inc.
|
140 | $1,820 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
43 | $1,456 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
This page
|
6 | $1,011 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
28 | $689 |
All Filings in NBIX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,011 | 6 | Shares | Sole | 2026-07-28 | |
| 2025-12-31 | $141 | 1 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $140 | 1 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $125 | 1 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $221 | 2 | Shares | Sole | 2025-04-28 | |
| No filing history on record for this holder in this stock. | ||||||